HARTOUNIAN HARTOUN has filed 4 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 225000 shares of BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | HARTOUNIAN HARTOUN | Director | A | Stock Option (Right to Buy) | 225000 | $0.70 | 225,000.0000 | 9,268,976 | 9999.99% | 2.43% |
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A | Common Stock | 50000 | $0.00 | 52,000.0000 | 5,021,798 | 2500.00% | 1.00% |
| June 24, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 4,315,903 | 9999.99% | 0.70% |
| June 24, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 4,315,903 | 9999.99% | 1.39% |